Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03838159
Title NADIM II: Neo-Adjuvant Immunotherapy (NADIMII)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fundacion GECP
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Nivolumab + Paclitaxel

Carboplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST